A Global Registry of COVID-19-related diabetes, the CoviDiab Registry, is being led by an international group of leading diabetes researchers

A Global Registry of COVID-19-related diabetes, the CoviDiab Registry, is being led by an international group of leading diabetes researchers

No ratings yet.

“This registry is specifically designed to establish the extent and characteristics of new-onset, COVID-19-related diabetes, and to investigate its pathogenesis, management and outcomes. The Registry also collects data about presentations with severe metabolic disturbance in pre-existing diabetes (DKA, hyperosmolarity; severe insulin resistance).”

Read more

Photo by PhotoMIX Company

Have comments, feedback, or suggestions?